Strathmore Capital Advisors, Inc. Abbott Laboratories Transaction History
Strathmore Capital Advisors, Inc.
- $244 Billion
- Q3 2025
A detailed history of Strathmore Capital Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Strathmore Capital Advisors, Inc. holds 3,945 shares of ABT stock, worth $501,015. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,945
Previous 3,837
2.81%
Holding current value
$501,015
Previous $511 Million
3.36%
% of portfolio
0.22%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,628Shares Held
1.38BCall Options Held
9.18MPut Options Held
8.02M-
Vanguard Group Inc Valley Forge, PA173MShares$22 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$9.95 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.64 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.3 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $222B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...